Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 16.48
+0.31 (1.92%)
Aug 20, 2026, 4:09 PM HKT
HKG:6826 Market Cap
HKG:6826 has a market cap or net worth of 7.8 billion as of August 20, 2026. Its market cap has decreased by -39.44% in one year.
Market Cap
7.80B
Enterprise Value
5.71B
Revenue
2.73B
Ranking
n/a
PE Ratio
14.32
Stock Price
16.48
ChartMarket Cap Chart
Since April 30, 2015, HKG:6826's market cap has decreased from 9.34B to 7.80B, a decrease of -16.54%. That is a compound annual growth rate of -1.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 7.79B | -23.39% |
| Dec 31, 2025 | 10.17B | -23.81% |
| Dec 31, 2024 | 13.35B | -24.15% |
| Dec 29, 2023 | 17.60B | 7.10% |
| Dec 30, 2022 | 16.43B | -29.33% |
| Dec 31, 2021 | 23.25B | 40.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 10.38B |
| Shaanxi Micot Pharmaceutical Technology | 10.15B |
| TenNor Therapeutics (Suzhou) | 9.31B |
| Suzhou Ribo Life Science | 8.78B |
| LongBio Pharma (Suzhou) | 8.64B |
| CARsgen Therapeutics Holdings | 8.44B |
| Everest Medicines | 8.36B |
| CStone Pharmaceuticals | 8.18B |